Duration of Treatment Effect Using IncobotulinumtoxinA for Upper-limb Spasticity: A Post-hoc Analysis

Duration of Treatment Effect Using IncobotulinumtoxinA for Upper-limb Spasticity: A Post-hoc Analysis

The efficacy and safety of incobotulinumtoxinA ≤400 U was demonstrated in subjects with post-stroke upper-limb spasticity in a randomized, double-blind Phase 3 study with an open-label extension (OLEX; EudraCT number 2005-003951-11, NCT00432666). We report a post-hoc analysis of the duration of the...

Full description

Bibliographic Details
Main Authors: Petr Kaňovský, Elie P. Elovic, Angelika Hanschmann, Irena Pulte, Michael Althaus, Reinhard Hiersemenzel, Christina Marciniak
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Neurology
Subjects:
duration of effect
incobotulinumtoxinA
post-stroke
upper-limb spasticity
treatment interval
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2020.615706/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2020.615706/full

Similar Items